treatment of chronic heart failure by the use of resynchronization therapy
Article Quality & Performance Metrics
Readership in this journal
SteadyRanked #29 of 231 articles by views in planta medica
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 231 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
Abstract: Chronic heart failure due to systolic dysfunction has been treated pharmacologically by the extensive use of ACE inhibitors, beta blockers, spyronolactone and digoksin improving morbidity, mortality and the quality of life as well as decreasing hospitalisation rate in the last decade. However, despite all the endeavors to optimize pharmacological treatment the mortality of the described syndrom remains unreasonably high and many patients suffer from severly expressed symptoms that considerably affect their quality of life. Thus, novel treatment modalities are being sought continuously and there is one, namely cardiac resynchronisation therapy which has gained increasing interest in the last couple of years.
| Reference Key |
gerak2005zdravnikitreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Borut Geršak;Aleš Brecelj;Maja Šoštarič;Nadja Ružič-Medvešček;Igor Zupan |
| Journal | planta medica |
| Year | 2005 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.